BioNexus Gene Lab (BGLC) EBT (2018 - 2026)
BioNexus Gene Lab recorded quarterly EBT of -$543575.0 in Q1 2026, up 47.54% quarter-over-quarter from -$1.0 million in Q4 2025, and up 12.79% year-over-year from -$481915.9 in Q1 2025.
BioNexus Gene Lab's EBT history runs 9 years deep, the most recent figure standing at -$543575.0 for Q1 2026.
- In Q1 2026, EBT rose 12.79% year-over-year to -$543575.0; the TTM figure through Mar 2026 stood at -$2.9 million (down 36.09% YoY), while the FY2025 annual figure was -$3.0 million, down 87.14% from the prior year.
- EBT came in at -$543575.0 for Q1 2026 at BioNexus Gene Lab, up from -$1.0 million in the prior quarter.
- In the past five years, EBT ranged from a high of $254688.0 in Q2 2024 to a low of -$2.5 million in Q3 2023.
- A 5-year average of -$472600.2 and a median of -$275241.0 in 2023 frame the typical range for EBT.
- On a YoY basis, EBT climbed as much as 298.96% in 2023 and fell as far as 3664.13% in 2023.
- BioNexus Gene Lab's EBT stood at -$127451.0 in 2022, then surged by 298.96% to $253571.0 in 2023, then tumbled by 266.44% to -$422032.0 in 2024, then plunged by 145.51% to -$1.0 million in 2025, then soared by 47.54% to -$543575.0 in 2026.
- According to Business Quant data, EBT over the past three periods registered -$543575.0, -$1.0 million, and -$708991.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT (Qtr) |
|---|---|---|---|---|---|
| 1 | Linde | 230.79 Bn | 226.84 Bn | 4.26 Bn | 2.43 Bn |
| 2 | Chemical & Mining Co Of Chile | 127.66 Bn | 124.93 Bn | 778.60 Mn | 686.80 Mn |
| 3 | Sherwin Williams | 72.51 Bn | 72.30 Bn | 2.78 Bn | 679.80 Mn |
| 4 | Ecolab | 70.96 Bn | 70.34 Bn | 1.85 Bn | 660.30 Mn |
| 5 | Air Products & Chemicals | 62.15 Bn | 63.70 Bn | 987.40 Mn | 883.50 Mn |
| 6 | Ppg Industries | 25.04 Bn | 23.57 Bn | 1.66 Bn | 517.00 Mn |
| 7 | LyondellBasell Industries | 21.62 Bn | 21.73 Bn | 701.00 Mn | 137.00 Mn |
| 8 | Albemarle | 20.26 Bn | 19.42 Bn | 500.97 Mn | 406.66 Mn |
| 9 | DuPont de Nemours | 19.45 Bn | 19.56 Bn | 602.00 Mn | 181.00 Mn |
| 10 | BioNexus Gene Lab | 5.34 Mn | 1.38 Mn | -790.00 | -543,575.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -543,575.00 |
| Dec 31, 2025 | -1.04 Mn |
| Sep 30, 2025 | -708,991.00 |
| Jun 30, 2025 | -616,172.00 |
| Mar 31, 2025 | -623,327.00 |
| Dec 31, 2024 | -422,032.00 |
| Sep 30, 2024 | -1.34 Mn |
| Jun 30, 2024 | 254,688.00 |
| Mar 31, 2024 | -83,689.00 |
| Dec 31, 2023 | 253,571.00 |
| Sep 30, 2023 | -2.53 Mn |
| Jun 30, 2023 | -275,241.00 |
| Mar 31, 2023 | -53,076.00 |
| Dec 31, 2022 | -127,451.00 |
| Sep 30, 2022 | -67,287.00 |
| Jun 30, 2022 | -140,283.00 |
| Mar 31, 2022 | 31,365.00 |
| Dec 31, 2021 | 197,077.00 |
| Sep 30, 2021 | 370,491.00 |
| Jun 30, 2021 | 136,542.00 |
| Mar 31, 2021 | 338,744.00 |
| Dec 31, 2020 | -7,591.00 |
| Sep 30, 2020 | 234,950.00 |
| Jun 30, 2020 | -35,354.00 |
| Mar 31, 2020 | 1.07 Mn |
| Dec 31, 2019 | -96,145.00 |
| Sep 30, 2019 | -50,138.00 |
| Jun 30, 2019 | -69,219.00 |
| Mar 31, 2019 | -60,203.00 |
| Dec 31, 2018 | -63,346.00 |
| Sep 30, 2018 | -55,142.00 |
| Mar 31, 2018 | 24,058.00 |